A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer
Clinical trial NCT02031744 · COMPLETED
Trial details
- NCT number
- NCT02031744
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-22
- Primary completion
- 2016-01-06
- Enrollment
- 530
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.